Clinical Trials Directory

Trials / Unknown

UnknownNCT01226199

The Expression of TLR2 and TLR4 in the Lung of Chronic Obstructive Pulmonary Disease (COPD) Patients

The Expression of TLR2 and TLR4 in the Lung of COPD Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Seoul National University Bundang Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Smoking is the most important risk factor of COPD, but only a fourth of smokers had COPD in their life. There are also healthy smokers without evidence of COPD. Investigators hypothesize that innate immunity may affect this difference between COPD patients and healthy smokers, because TLR4 is the receptor of LPS, which is the one of important substance in cigarette. Investigators will measure TLR2 and TLR4 expression in lung tissue of patients whose lung will be resected. Investigators will compare the level of expression between COPD patients and healthy smokers.

Conditions

Timeline

Start date
2010-10-01
Primary completion
2011-12-01
Completion
2012-03-01
First posted
2010-10-22
Last updated
2011-06-08

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01226199. Inclusion in this directory is not an endorsement.